Integrative multi-omics and preclinical analyses identify miR-4776-5p as a prognostic radiosensitizer for patients undergoing radiotherapy for head-and-neck cancer.

In our qRT-PCR validation (Figure S4), the changes in expression of six potential target genes did not reach statistical significance (p > 0.05) after transfection with miR-4776-5p mimics.

also in 111,027 other papers